Read More Healthcare Industry News Biodesix acquires Oncimmune’s laboratory and IPN malignancy test in US Biodesix, a lung cancer diagnostic solutions company, has acquired UK-based Oncimmune’s laboratory and incidental pulmonary nodule (IPN) malignancy… bypharmanewsdailyNovember 4, 2019